UDP-galactose:β-
A novel gene defining a novel enzyme in the UDP-D-galactose: β-N-acetylglucosamine / β-N-acetylgalactosamine β 1,3 galactosyltransferase family, termed β 3 Gal-T 5 , with unique enzymatic properties is disclosed. The enzymatic activity of β 3 Gal-T 5 is shown to be distinct from that of previously identified enzymes of this gene family. The invention discloses isolated DNA molecules and DNA constructs encoding β 3 Gal-T 5 and derivatives thereof by way of amino acid deletion, substitution or insertion exhibiting β 3 Gal-T 5 activity, as well as cloning and expression vectors including such DNA, cells transfected with the vectors, and recombinant methods for providing β 3 Gal-T 5 . The enzyme β 3 Gal-T 5 and β 3 Gal-T 5 -active derivatives thereof are disclosed, in particular soluble derivatives comprising the catalytically active domain of β 3 Gal-T 5 . Further, the invention discloses methods of obtaining β 1,3 galactosyl glycosylated saccharides, glycopeptides or glycoproteins by use of an enzymatically active β 3 Gal-T 5 protein or, fusion protein thereof or by using cells stably transfected with a vector including DNA encoding an enzymatically active β 3 Gal-T 5 protein as an expression system for recombinant production of such glycopeptides or glycoproteins. Also a method for the identification of DNA sequence variations in the β 3 Gal-T 5 gene by isolating DNA from a patient, amplifying β 3 Gal-T 5 -coding exons by PCR, and detecting the presence of DNA sequence variation, are disclosed.
1. An isolated polypeptide comprising amino acids 25-310 of SEQ ID NO: 9, or an enzymatically active fragment thereof, wherein said polypeptide or enzymatically active fragment thereof has β-N-acetylglucosamine β1,3galactosyltransferase (β3Gal-T5) enzymatic activity.
2. The polypeptide of claim 1 , consisting of amino acids 25-310 of SEQ ID NO: 9.
3. The polypeptide of claim 1 , wherein the enzymatically active fragment comprises at least 200 residues selected from amino acids 25-310 of SEQ ID NO: 9.
4. An isolated polypeptide comprising at least 200 residues selected from amino acids 25-310 of SEQ ID NO:9, wherein said polypeptide has β-N-acetylglucosamine β1,3galactosyltransferase (β3Gal-T5) enzymatic activity.
5. The polypeptide of claim 4 , said polypeptide having the property of binding immunospecifically to an antibody raised against a β-N-acetylglucosamine β1,3galactosyltransferase (β3Gal-T5 ) polypeptide.
6. A fusion protein comprising the polypeptide of claim 4 fused by a covalent bond to an amino acid sequence of a second protein, which second protein is not a β-N-acetylglucosamine β1,3galactosyltransferase (β3Gal-T5) polypeptide.
7. The polypeptide of claim 1 , said polypeptide having the property of transferring galactose through a β1-3 linkage to an acceptor substrate selected from the group consisting of GalNAcβ1-3Galα1-4Galβ1-4Glcβ1-Cer, Glcβ1-Cer, GalNAcβ1-4Galβ1-4Glcβ1-Cer, GlcNAcβ1-3 Galβ1-4Glcβ1-Cer, and GlcNAcβ1-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ1-Cer.
8. An isolated polypeptide comprising at least 200 residues selected from amino acids 25-310 of SEQ ID NO:9, which polypeptide has the property of transferring galactose through a β1-3 linkage to GalNAcβ1-3Galα1-4Galβ1-4Glcβ1-Cer.
9. An isolated polypeptide consisting of 200 or more contiguous residues selected from amino acids 25-310 of SEQ ID NO:9, wherein said polypeptide has β-N-acetylglucosamine β1,3galactosyltransferase (β3Gal-T5) enzymatic activity.
10. An isolated polypeptide consisting of amino acids 25-310 of SEQ ID NO:9, or an enzymatically active fragment thereof, wherein the polypeptide or fragment thereof has the property of transferring galactose through a β1-3 linkage to globoside.
11. An isolated polypeptide comprising amino acids 25-310 of SEQ ID NO:9, or an enzymatically active fragment thereof, wherein the polypeptide or fragment thereof has the property of transferring galactose β1-3 to an acceptor substrate selected from the group consisting of a glycoprotein or a glycolipid.